Truist Financial Issues Positive Forecast for Guardian Pharmacy Services (NYSE:GRDN) Stock Price

Guardian Pharmacy Services (NYSE:GRDNGet Free Report) had its price objective upped by stock analysts at Truist Financial from $30.00 to $34.00 in a note issued to investors on Friday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price target suggests a potential upside of 16.98% from the company’s current price.

Several other equities analysts also recently weighed in on the stock. Oppenheimer started coverage on shares of Guardian Pharmacy Services in a report on Friday, October 10th. They set an “outperform” rating and a $30.00 target price for the company. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “sell (d+)” rating to a “hold (c)” rating in a report on Tuesday. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 9th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $30.67.

Get Our Latest Stock Report on GRDN

Guardian Pharmacy Services Stock Down 4.5%

NYSE:GRDN traded down $1.36 during midday trading on Friday, hitting $29.07. The stock had a trading volume of 229,928 shares, compared to its average volume of 218,889. The company has a market capitalization of $1.84 billion, a price-to-earnings ratio of 46.14 and a beta of 0.96. Guardian Pharmacy Services has a one year low of $17.78 and a one year high of $37.43. The stock has a 50-day moving average of $27.02 and a 200 day moving average of $24.07.

Guardian Pharmacy Services (NYSE:GRDNGet Free Report) last issued its quarterly earnings results on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The company had revenue of $377.43 million for the quarter, compared to the consensus estimate of $381.16 million. Guardian Pharmacy Services has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Guardian Pharmacy Services will post 0.87 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors have recently made changes to their positions in GRDN. Ameritas Investment Partners Inc. lifted its holdings in Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after acquiring an additional 345 shares during the period. Envestnet Asset Management Inc. raised its position in shares of Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after purchasing an additional 805 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its stake in Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after purchasing an additional 1,062 shares in the last quarter. State of Alaska Department of Revenue acquired a new position in Guardian Pharmacy Services during the third quarter worth $30,000. Finally, Allspring Global Investments Holdings LLC boosted its stake in Guardian Pharmacy Services by 0.5% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock valued at $6,092,000 after purchasing an additional 1,338 shares during the period.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.